Commentaries by date:
Assessing the Evidence Series By Rebecca L Diekemper, MPH, Doctor Evidence, Santa Monica, CA, Belinda K Ireland, MD, MS, TheEvidenceDoc,…
Read MoreBy Craig Whittington, PhD and Jacob Franek, MHSc Introduction GROWTH commentaries started in November 2014, and have covered a broad…
Read MoreBy David Meyers, M.D. Chief Medical Officer, AHRQ Introduction One of my favorite things about attending large conferences is bumping…
Read MoreBy Anna R Gagliardi, PhD Scientist, Toronto General Hospital Research Institute, University Health Network Associate Professor, University of Toronto Chair,…
Read MoreChanging medical culture and providing care providers and patients with needed information, thereby achieving quality, value, and truly informed consent…
Read MoreBy Sally C. Morton, PhD Professor and Chair, Department of Biostatistics University of Pittsburgh Vice Chair, IOM Committee on Standards for…
Read MoreBy Peg Ford, Co-Founder/President Ovarian Cancer Alliance of San Diego My entry into the world of medical research was due to a…
Read MoreBy Tom Oliver, Director Quality and Guidelines, American Society of Clinical Oncology Introduction The Guideline Program of the American Society of Clinical Oncology (ASCO)…
Read More
Risk of Bias in Randomized Trials
Assessing the Evidence Series By Gordon H. Guyatt, MD, MSc and Jason W. Busse, DC, PhD Risk of Bias: A Better…
Read More